tiprankstipranks
Trending News
More News >
BioLineRX Ltd. (IL:BLRX)
:BLRX
Israel Market

Bioline Rx (BLRX) Income Statement

Compare
2 Followers

Bioline Rx Income Statement

Last quarter (Q2 2025), Bioline Rx's total revenue was $304.00K, a decrease of -94.36% from the same quarter last year. In Q2, Bioline Rx's net income was $-3.94M. See Bioline Rx’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 28.94M$ 4.80M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 19.68M$ 1.11M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 40.09M$ 50.80M$ 29.16M$ 24.78M$ 22.93M
Depreciation and Amortization
$ 4.07M$ 1.38M$ 654.00K$ 703.00K$ 934.00K
EBITDA
$ 3.92M$ -57.09M$ -28.50M$ -24.07M$ -21.99M
Operating Income
$ -20.41M$ -49.69M$ -29.16M$ -24.78M$ -22.93M
Other Income/Expenses
$ 11.19M$ -10.92M$ 4.21M$ -2.28M$ -7.09M
Pretax Income
$ -9.22M$ -60.61M$ -24.95M$ -27.05M$ -30.02M
Net Income
$ -9.22M$ -60.61M$ -20.75M$ -28.14M$ -30.93M
Per Share Metrics
Basic EPS
$ -0.01$ -0.06$ -0.03$ -0.04$ -0.12
Diluted EPS
$ -0.01$ -0.06$ -0.03$ -0.04$ -0.12
Weighted Average Shares Outstanding
1.20B 963.37M 773.96M 662.93M 252.84M
Weighted Average Shares Outstanding (Diluted)
1.20B 963.37M 773.96M 662.93M 252.84M
Currency in USD

Bioline Rx Earnings and Revenue History